– Oversubscribed Series B round led by TPG includes prominent group of new and existing investors, bringing total raised to-date to over $110 million– Funding supports rapid clinical development of targeted ADC therapeutics in difficult-to-treat cancers – Chris LeMasters joins as Independent Board Member, bringing 2...